✦ LIBER ✦

Could specific oral tolerance be a therapy for autoimmune disease?

✍ Scribed by H Stephen; G Thompson; Norman A Staines

Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 633 KB
Volume: 11
Category: Article
ISSN: 0167-5699
DOI: 10.1016/0167-5699(90)90158-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary observations of oral nicotin

Preliminary observations of oral nicotine therapy for inflammatory bowel disease: An open-label phase I-II study of tolerance

✍ John Robert Ingram; John Rhodes; Brian K Evans; Dr. Gareth A. O. Thomas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Background: Transdermal nicotine provides benefit in active ulcerative colitis but is often associated with adverse events (aes). an oral formulation has been developed to minimize aes. this study was undertaken to make initial observations on the safety and tolerance of oral nicotine therapy in

Chemotherapy in patients with prostate s

Chemotherapy in patients with prostate specific antigen–only disease after primary therapy for prostate carcinoma : A Phase II trial of oral estramustine and oral etoposide

✍ Hidayatullah G. Munshi; Kenneth J. Pienta; David C. Smith 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## BACKGROUND. A Phase II study was initiated to evaluate the effectiveness of an oral regimen of etoposide and estramustine in patients with early recurrent prostate carcinoma. ## METHODS. Patients with early recurrent prostate carcinoma as indicated by an increasing prostate specific antigen